Active BE 0803.966.583Private limited company

NZOSSHEALTH

Vootstraat 94 ·1200 Sint-Lambrechts-Woluwe, Belgium· 3 yrs active

Sector: Detailhandel in farmaceutische producten (47730)

Conclusion Checked

The computed 12-month bankruptcy probability of NZOSSHEALTH is 3.6% (moderate). The 2024 annual accounts show equity of €125k and a net result of €76k. Its solvency ranks better than 95% of 6720 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Key figures

Equity	€125k
Net result	€76k
Better than sector	95%
Active	3 yrs

Financial profile 5 of 5 axes measured · computed by Checked

94 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100

Profitability 100

Solvency 100

Growth 78

Stability 94

Bankruptcy probability (12 mo) Checked model v1 · free

3.6% Moderate

0%0,5%1,5%4%10%≥25%

Young company +Higher-failure-rate region +Higher-failure-rate sector +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based

0 / 100

Low risk

Trust signals 2 signals

More than 3 years active

Founded in 2023, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags0 events

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Health barometer FY 2024 · computed

100 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Financial overview2 NBB filings

Annual accounts filed on 10-07-2025 with the NBB · fiscal year 2024 · micro

Operating resultNet result

Sector comparison

Fiscal year 2024 · NACE 47, Retail trade · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	91.1%	20.4%	better than 95% of 6720 sector peers
Net result	€76k	€4k	better than 94% of 6701 sector peers
Equity	€125k	€16k	better than 89% of 6735 sector peers
Gross operating margin	€96k	€24k	better than 81% of 6680 sector peers
Staff costs	€100	€33k	higher than 5% of 3047 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€95k

- 23-24

Net profit

€76k

+48.2% 23-24

Cash flow

€76k

- 23-24

Total assets

€138k

+115.7% 23-24

Equity

€125k

+147.5% 23-24

Working capital

€124k

+144.6% 23-24

Staff costs

€100

- 23-24

Income taxes

€19k

+50.7% 23-24

Show 10 other metrics

Dividends

€859

+3.1% 23-24

Debt

€12k

-6.9% 23-24

Debt ≤ 1y

€12k

-6.9% 23-24

Current ratio

11.13

+129.3% 23-24

Quick ratio

11.13

+129.3% 23-24

Solvency

91.1%

+14.8% 23-24

Debt / equity

0.10

-62.4% 23-24

ROE

60.3%

-40.1% 23-24

ROA

54.9%

-31.3% 23-24

Interest coverage

837.76

- 23-24

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2024
Deposit	micro
Revenue	-
EBITDA	€95k
Net profit	€76k
Cash flow	€76k
Staff costs	€100
Income taxes	€19k
Dividends	€859
Total assets	€138k
Equity	€125k
Debt	€12k
of which ≤ 1y	€12k
of which > 1y	-
Working capital	€124k
Employees (FTE)	-

Ratios (computed)

	2024
Current ratio	11.13
Quick ratio	11.13
Working capital ratio	90.0%
Solvency	91.1%
Debt / equity	0.10
Long-term debt ratio	-
Interest coverage	837.76
Gross margin	-
Net margin	-
ROA	54.9%
ROE	60.3%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2024

Assets

Fixed assets €1k · 1.1% Current assets €136k · 98.9%

Equity & liabilities

Equity €125k · 91.1% Debt €12k · 8.9%

Full annual accounts (21 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€138k
Fixed assets	21/28	€1k
Tangible fixed assets	22/27	€1k
Current assets	29/58	€136k
Amounts receivable within one year	40/41	€8k
Cash & bank	54/58	€128k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€138k
Equity	10/15	€125k
Contributions / capital	10/11	€500
Accumulated profits (losses)	14	€125k
Amounts payable	17/49	€12k
Amounts payable within one year	42/48	€12k
Trade debts payable within one year	44	€136
Income statement
Gross operating margin	9900	€96k
Operating result	9901	€95k
Financial income	75	€0
Financial charges	65	€114
Result before taxes	9903	€95k
Income taxes	67/77	€19k
Net result for the period	9904	€76k
Result to be appropriated	9905	€76k

This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan. See plans →

Ratios computed by Checked.

Legal Structure

NACE primary	Detailhandel in farmaceutische producten(47730)
Legal form	Private limited company(610)
Incorporation	14-07-2023
Status	Active
Postal code	1200

Establishment units 1 location

NZOSSHEALTH

Zénobe Grammelaan 85, 1030 SchaarbeekVervaardiging van overige farmaceutische producten

since 20232.347.708.816

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 2 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
21015A0120/00F000	Brussels	897 m²	1 · 685 m²	22.7 m · 7 fl.
21018B0153/00Y008	Brussels	172 m²	1 · 109 m²	13.2 m · 3 fl.

Methodology

via registered seat: 1 · via establishment units: 1

2 of 2 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Updates 2 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025

10-07-2025

NBB filing Annual accounts filed

fiscal year 2024 · micro

2024

20-06-2024

NBB filing Annual accounts filed

fiscal year 2023 · micro

Belgian State Gazette reading coverage 0 of 1 acts read

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Credit advice verdict per customer and amount

Company registry (CBE) Crossroads Bank

Activities

Apotheken47730Detailhandel in farmaceutische producten47730Vervaardiging van overige farmaceutische producten21209Vervaardiging van overige farmaceutische producten21209Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels47740Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen47741Overige zakelijke dienstverlening, n.e.g.82990Overige zakelijke dienstverlening, neg82990

Primary activity highlighted.

Names & trade names

Legal nameFR

NZOSSHEALTH

Registered office

Vootstraat 94

1200 Sint-Lambrechts-Woluwe, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.

Similar companies Comparable size · 500 of 5,224 companies in this sector with filed accounts

APOTHEEK DELANG - GOOSSENS BE 0448.489.990 · Sint-Katelijne-Waver

AC CONSULT BE 0544.409.629 · Hasselt

APOTHEEK HANSEN BE 0662.810.106 · Tongeren-Borgloon

PHARMACIE RASSON BE 0472.529.164 · Péruwelz

Pharmacie Blaes BE 0775.650.996 · Brussel